[HTML][HTML] COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities
In 2022, students at North American universities with third-dose COVID-19 vaccine
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …
COVID-19 booster uptake among US adults: assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment
Objective Evidence shows that booster shots offer strong protection against the Omicron
variant of COVID-19. However, we know little about why individuals would receive a booster …
variant of COVID-19. However, we know little about why individuals would receive a booster …
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations
P Kardos, J Correia de Sousa, U Heininger… - Human Vaccines & …, 2024 - Taylor & Francis
Pertussis has several notable consequences, causing economic burden, increased strain on
healthcare facilities, and reductions in quality of life. Recent years have seen a trend toward …
healthcare facilities, and reductions in quality of life. Recent years have seen a trend toward …
A hierarchy of medical countermeasures against biological threats
AT Biggs, LF Littlejohn - Military medicine, 2022 - academic.oup.com
Introduction Emerging biological threats represent a serious challenge for force health
protection (FHP). Against a novel biological threat, medical countermeasures are the first …
protection (FHP). Against a novel biological threat, medical countermeasures are the first …
[HTML][HTML] Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen …
P Pitisuttithum, J Dhitavat, C Sirivichayakul… - …, 2021 - thelancet.com
Background Recombinant pertussis vaccines inducing long-lasting immune responses
could help to control the rise in pertussis. We here report on persisting antibody responses 2 …
could help to control the rise in pertussis. We here report on persisting antibody responses 2 …
Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016
VD Bampoe, N Brown, L Deng, J Schiffer… - Clinical Infectious …, 2024 - academic.oup.com
Background Tetanus, a life-threatening infection, has become rare in the United States since
introduction of tetanus toxoid-containing vaccines (TTCVs), recommended as a childhood …
introduction of tetanus toxoid-containing vaccines (TTCVs), recommended as a childhood …
Herd immunity, vaccination and moral obligation
M Bullen, GS Heriot, E Jamrozik - Journal of Medical Ethics, 2023 - jme.bmj.com
The public health benefits of herd immunity are often used as the justification for coercive
vaccine policies. Yet,'herd immunity'as a term has multiple referents, which can result in …
vaccine policies. Yet,'herd immunity'as a term has multiple referents, which can result in …
Tetanus, analysis of 29 cases
A Pérez-González, I Fernández-Castro… - Medicina Clínica, 2022 - Elsevier
Background Tetanus disease is caused by Clostridium tetani, an anaerobe bacteria found in
dust and soil. Once reached human body through damaged tissues, C. tetani releases …
dust and soil. Once reached human body through damaged tissues, C. tetani releases …
COVID-19 vaccine boosters for young adults: A risk-benefit assessment and five ethical arguments against mandates at universities
Abstract Students at North American universities risk disenrollment due to third dose COVID-
19 vaccine mandates. We present a risk-benefit assessment of boosters in this age group …
19 vaccine mandates. We present a risk-benefit assessment of boosters in this age group …
[HTML][HTML] Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus …
L Fortuna, S Chaithongwongwatthana… - Vaccine, 2020 - Elsevier
A new generation of recombinant acellular pertussis vaccine containing genetically
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …